ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,871Medicare Part D Prescriptions Filled, Including Refills

Rank: 116 out of 783

$929K Total Retail Price of All Prescriptions

Rank: 60 out of 783

697 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 697 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 697 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 10,928 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 446 393 1 1
SIMVASTATIN 435 403 2 3
AMLODIPINE BESYLATE 397 361 3 5
ATORVASTATIN CALCIUM 326 296 4 11
LISINOPRIL 314 300 5 4
OMEPRAZOLE 305 282 6 6
HYDROCODONE-ACETAMINOPHEN 279 203 S3 7 2
METOPROLOL SUCCINATE 253 223 8 13
HYDROCHLOROTHIAZIDE 230 213 9 12
FUROSEMIDE 214 180 10 7
METFORMIN HCL ER 205 185 11 64
CITALOPRAM HBR 186 161 12 19
WARFARIN SODIUM 174 166 13 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 172 167 14 33
POTASSIUM CHLORIDE 157 124 15 16
PRAVASTATIN SODIUM 154 113 16 14
ZOLPIDEM TARTRATE 150 147 17 23
CARVEDILOL 143 126 18 21
ATENOLOL 138 137 19 17
CLOPIDOGREL 136 123 20 29
METOPROLOL TARTRATE 130 127 21 9
TRIAMTERENE-HCTZ 126 121 22 42
FAMOTIDINE 123 90 23 55
LOSARTAN POTASSIUM 123 119 23 18
PANTOPRAZOLE SODIUM 122 102 25 30
GLIMEPIRIDE 119 115 26 34
ALENDRONATE SODIUM 118 118 27 25
FLUTICASONE PROPIONATE 114 76 28 46
PLAVIX 108 101 29 51
CLONIDINE HCL 108 65 29 60
GABAPENTIN 102 85 31 15
DOXAZOSIN MESYLATE 102 93 31 87
SERTRALINE HCL 93 75 33 22
AZITHROMYCIN 92 72 34 41
LOSARTAN-HYDROCHLOROTHIAZIDE 90 86 35 53
ISOSORBIDE MONONITRATE ER 89 85 36 40
LIPITOR 83 83 37 114
ALLOPURINOL 80 79 38 31
DONEPEZIL HCL 76 76 39 24
MELOXICAM 74 70 40 37
SYNTHROID 74 74 40 47
TAMSULOSIN HCL 73 55 42 26
GLIPIZIDE ER 73 73 42 84
TRAMADOL HCL 70 66 44 20
LANTUS 69 56 45 38
BENAZEPRIL HCL 68 55 46 85
NAMENDA 68 68 46 32
AMLODIPINE BESYLATE-BENAZEPRIL 68 55 46 83
PROPRANOLOL HCL 67 35 49 129
CRESTOR 67 54 49 27
DIOVAN HCT 67 67 49 94
RAMIPRIL 65 54 52 113
PREDNISONE 64 58 53 36
DIOVAN 62 56 54 49
CYMBALTA 59 55 55 35
TRAZODONE HCL 59 53 55 39
LEVOXYL 58 58 57 150
LYRICA 57 45 58 98
EVISTA 57 43 58 92
ADVAIR DISKUS 57 28 58 50
JANUVIA 56 56 61 73
EXELON 56 56 61 109
NITROSTAT 55 33 63 191
METFORMIN HCL 55 47 63 8
GLIPIZIDE 54 54 65 71
LANTUS SOLOSTAR 54 39 65 91
VENLAFAXINE HCL ER 54 43 65 100
CYCLOBENZAPRINE HCL 52 19 R 68 63
ALPRAZOLAM 51 48 69 145
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.